| Vera A Depalo, MD | |
|
725 Reservoir Ave Ste 6a, Cranston, RI 02910 | |
| (401) 829-4446 | |
| (401) 829-4434 |
| Full Name | Vera A Depalo |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 37 Years |
| Location | 725 Reservoir Ave Ste 6a, Cranston, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659354546 | NPI | - | NPPES |
| 110087809A | Medicaid | MA | |
| 7004345 | Medicaid | RI | |
| 0070043451 | Other | RI | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | MD08654 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Home & Hospice Care Of Rhode Island | Providence, RI | Hospice |
| Elderwood Of Scallop Shell At Wakefield | South kingstown, RI | Nursing home |
| Hattie Ide Chaffee Home | East providence, RI | Nursing home |
| St Clare Home | Newport, RI | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trucare Inc | 1850646811 | 5 |
News Archive
A new analysis that compares two common inhalers for patients suffering from chronic obstructive pulmonary disease (COPD) finds that one reduces respiratory-related hospitalizations and respiratory deaths, but the other - which is prescribed in the majority of cases - increases respiratory deaths.
The U.S. Food and Drug Administration today approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo). This is the first drug approved for this use.
Though heart disease is a major cause of disability and death, very little is understood about its genetic underpinnings. Recently, an international team of investigators at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Sanford-Burnham Medical Research Institute (Sanford-Burnham) and other organizations shed new light on the subject.
Your road map would turn the federal contribution to health care into a voucher (which I don't view as a dirty word). But the vouchers it would offer … are at levels so far below current insurance premiums as to make it likely you'd be shifting costs to millions who can't afford them (Matt Miller, 8/23).
› Verified 2 days ago
| Entity Name | Trucare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538659081 PECOS PAC ID: 1850646811 Enrollment ID: O20180614001472 |
News Archive
A new analysis that compares two common inhalers for patients suffering from chronic obstructive pulmonary disease (COPD) finds that one reduces respiratory-related hospitalizations and respiratory deaths, but the other - which is prescribed in the majority of cases - increases respiratory deaths.
The U.S. Food and Drug Administration today approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo). This is the first drug approved for this use.
Though heart disease is a major cause of disability and death, very little is understood about its genetic underpinnings. Recently, an international team of investigators at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Sanford-Burnham Medical Research Institute (Sanford-Burnham) and other organizations shed new light on the subject.
Your road map would turn the federal contribution to health care into a voucher (which I don't view as a dirty word). But the vouchers it would offer … are at levels so far below current insurance premiums as to make it likely you'd be shifting costs to millions who can't afford them (Matt Miller, 8/23).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vera A Depalo, MD 725 Reservoir Ave Ste 6a, Cranston, RI 02910-4450 Ph: (401) 944-6889 | Vera A Depalo, MD 725 Reservoir Ave Ste 6a, Cranston, RI 02910 Ph: (401) 829-4446 |
News Archive
A new analysis that compares two common inhalers for patients suffering from chronic obstructive pulmonary disease (COPD) finds that one reduces respiratory-related hospitalizations and respiratory deaths, but the other - which is prescribed in the majority of cases - increases respiratory deaths.
The U.S. Food and Drug Administration today approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo). This is the first drug approved for this use.
Though heart disease is a major cause of disability and death, very little is understood about its genetic underpinnings. Recently, an international team of investigators at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Sanford-Burnham Medical Research Institute (Sanford-Burnham) and other organizations shed new light on the subject.
Your road map would turn the federal contribution to health care into a voucher (which I don't view as a dirty word). But the vouchers it would offer … are at levels so far below current insurance premiums as to make it likely you'd be shifting costs to millions who can't afford them (Matt Miller, 8/23).
› Verified 2 days ago
Susan H Hart, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1052 Park Ave, Cranston, RI 02910 Phone: 401-275-5039 | |
Thomas Henry Mcgreen, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1150 Reservoir Ave, Suite 201, Cranston, RI 02920 Phone: 401-943-1300 Fax: 401-946-8480 | |
Dr. Gregory G Allen, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1681 Cranston St, Suite D, Cranston, RI 02920 Phone: 401-946-8446 Fax: 401-946-8340 | |
Dr. Robert L Graves, D.O. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1150 Reservoir Ave, Suite 304, Cranston, RI 02920 Phone: 401-942-3330 Fax: 401-942-3833 | |
Dr. Robert John Bierwirth, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1150 Reservoir Ave, Suite 201, Cranston, RI 02920 Phone: 401-943-1300 | |
Dr. Steven Michael Sepe, M.D., PH.D Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 25 Belle Isle Way, Cranston, RI 02921 Phone: 401-942-7843 Fax: 401-942-7843 | |
Ms. Jun O Parks, M. D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 333 Budlong Rd, Cranston, RI 02920 Phone: 401-943-4530 |